Panagora Asset Management’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-31,912
| Closed | -$913K | – | 2651 |
|
|
2018
Q4 | $913K | Buy |
31,912
+11,058
| +53% | +$314K | ﹤0.01% | 1119 |
|
|
2018
Q3 | $582K | Sell |
20,854
-990
| -5% | -$27.8K | ﹤0.01% | 1332 |
|
|
2018
Q2 | $609K | Sell |
21,844
-4,312
| -16% | -$116K | ﹤0.01% | 1338 |
|
|
2018
Q1 | $650K | Sell |
26,156
-2,530
| -9% | -$61.5K | ﹤0.01% | 1309 |
|
|
2017
Q4 | $695K | Buy |
+28,686
| New | +$756K | ﹤0.01% | 1265 |
|
|
2017
Q1 | – | Sell |
-71,334
| Closed | -$1.87M | – | 2491 |
|
|
2016
Q4 | $1.87M | Sell |
71,334
-5,226
| -7% | -$129K | 0.01% | 925 |
|
|
2016
Q3 | $1.91M | Buy |
76,560
+65,189
| +573% | +$1.52M | 0.01% | 922 |
|
|
2016
Q2 | $247K | Hold |
11,371
| – | – | ﹤0.01% | 1598 |
|
|
2016
Q1 | $170K | Buy |
11,371
+9,050
| +390% | +$152K | ﹤0.01% | 1711 |
|
|
2015
Q4 | $51K | Sell |
2,321
-76,350
| -97% | -$1.42M | ﹤0.01% | 1978 |
|
|
2015
Q3 | $1.24M | Buy |
78,671
+76,773
| +4,045% | +$1.23M | 0.01% | 939 |
|
|
2015
Q2 | $27K | Buy |
+1,898
| New | +$32.1K | ﹤0.01% | 2263 |
|
|
2015
Q1 | – | Sell |
-7,457
| Closed | -$134K | – | 2413 |
|
|
2014
Q4 | $134K | Buy |
+7,457
| New | +$120K | ﹤0.01% | 1774 |
|
Other funds holding NXTM
Panagora Asset Management's NXTM Position: Q1 2019 in Review
Panagora Asset Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 31,912 shares — an estimated $913K sold.
Panagora Asset Management first reported a position in NXTM in Q4 2014 and held it in 13 quarters. The position peaked at $1.91M in Q3 2016. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Panagora Asset Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Panagora Asset Management sold 31,912 NxStage Medical Inc. shares in Q1 2019, an estimated $913K.
- Panagora Asset Management first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 13 quarters.
- Panagora Asset Management's NxStage Medical Inc. position peaked at $1.91M in Q3 2016.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Panagora Asset Management's 13F filing for Q1 2019, filed 15 May 2019.